Skip to main content

Mechanistic Evaluation of the Effect of Sintering on Compritol® 888 ATO Matrices

Abstract

The present research studied the effect of sintering technique in the development of a controlled release formulation for ketorolac tromethamine. The method consisted of mixing drug and wax powder (Compritol® 888 ATO) along with lactose as diluent and talc as lubricant followed by direct compression at room temperature. The compressed fluffy matrices were kept at 80°C for 1, 2, and 3 h for sintering. The sintered tablets were characterized by their physical parameters and in vitro dissolution profile. The sintering time markedly affected the drug release properties of Compritol® 888 ATO matrices. It is notable that the release rate of ketorolac tromethamine from matrices was inversely related to the time of sintering. This may be due to the increase in the extent and firmness of sintering which further compacts the mass so that drug release is affected. Contact angle measurement and scanning electron microscopy analysis indicated that heat treatment caused the wax to melt and redistribute. This redistributed wax formed a network-like structure in which the drug along with lactose is entrapped. This particular formed matrix is responsible for retarding the drug release. Fourier transform infrared spectroscopy results did not show any drug–wax interaction due to sintering. Differential scanning calorimetric and powder X-ray diffraction studies ruled out the occurrence of solid solution and polymorphic changes of the drug. Drug release from the wax tablets with or without sintering was best described by the Higuchi equation.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

References

  1. Y. Zhang, and B. Schwartz. Effect of processing method and heat treatment on formulation of wax matrix tablet. Pharm. Dev. Tech. 69:131–144 (2001).

    Article  Google Scholar 

  2. S.B. Tiwari, T. Krishnamurthy, M.R. Pai, P. R. Mehta, and P.B. Choudhary. Controlled release formulation of tramadol hydrochloride using hydrophilic and hydrophobic matrix system. AAPS Pharm. Sci. Tech. 4:31 (2003).

    Article  Google Scholar 

  3. C.L. Luk, and H.L. Jane. Sintering in pharmaceutics. In J. Swarbrick, and J. C. Boylan (eds.), Encyclopedia of Pharmaceutical Technology, 14:2nd ed., Marcel Dekker, New York, 1996, pp. 87–101.

    Google Scholar 

  4. S.B. Rao, P.S. Cheruvu, K.S. Sudha et al. Studies on release of rifampicin from sintered matrix tablets. Indian J. Pharm. Sci. 63:371–378 (2001).

    Google Scholar 

  5. S.B. Rao, A. Seshsayana, K. Himasankar et al. Design and evaluation of ethylene vinyl acetate sintered matrix tablets. Indian J. Pharm. Sci. 65:496–502 (2003).

    CAS  Google Scholar 

  6. A. Kondaiah, and K. Prakash. Design of controlled release non-erodible polymeric matrix tablets of theophylline using sintering technique. Indian J. Pharm. Sci. 64:239–243 (2002).

    CAS  Google Scholar 

  7. S.B. Rao, K.H. Sankar, and B.S. Sirisha. Design and evaluation of Eudragit RL100 sintered matrix tablets. Indian J. Pharm. Sci. 66:202–207 (2004).

    CAS  Google Scholar 

  8. S. Azarmi, J. Farid, A. Nokhodechi, and H. Valizadeh. Thermal treating as a tool for sustained release of indomethacin from Eudragit RS and RL matrices. Int J. Pharm. 246:171–177 (2002).

    PubMed  Article  CAS  Google Scholar 

  9. D. Jung, E. Mroszczak, and L. Bynum. Pharmacokinetics of ketorolac tromethamine in humans after intravenous, intramuscular and oral administration. Eur. J. Clin. Pharmacol. 35:423–425 (1988).

    PubMed  Article  CAS  Google Scholar 

  10. E.J. Mroszczak, F.W. Lee, and D. Combs. Ketorolac tromethamine absorption, distribution, metabolism, excretion and pharmacokinetics in animals and humans. Drug Metab. Dispos. 15:618–626 (1987).

    PubMed  CAS  Google Scholar 

  11. J.B. Brubach, V. Jannin, B. Mahler, and P. Roy. Structural and thermal characterization of glyceryl behenate by X-ray diffraction coupled to differential calorimetry and infrared spectroscopy. Int. J. Pharm. 336:248–256 (2007).

    PubMed  Article  CAS  Google Scholar 

  12. S.B. Souto, W. Mehnert, and R.H. Muller. Polymorphic behaviour of Compritol 888 ATO as a bulk lipid and as SLN and NLC. J. Microencapsul. 234:417–433 (2006).

    PubMed  Article  CAS  Google Scholar 

  13. R. Singh, S.S. Poddar, and A. Chivate. Sintering of wax for controlling release from pellets. AAPS Pharm. Sci. Tech. 8:E1–E9 (2007).

    Article  Google Scholar 

  14. S. Azarmi, F. Ghaffari, R. Lobenberg, and A. Nokhodchi. Mechanistic evaluation of the effect of thermal treating on Eudragit RS matrices. II Farmaco. 60:925–930 (2005).

    Article  CAS  Google Scholar 

  15. H.M. Abdou. Dissolution, Bioavailability and Bioequivalence, Mack, Easton, 1989.

    Google Scholar 

Download references

Acknowledgments

The authors would like to thank Dr. K.G. Bothara, Principal, AISSMS College of Pharmacy, Pune for his constant support and encouragement.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Monica Rao.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Rao, M., Ranpise, A., Borate, S. et al. Mechanistic Evaluation of the Effect of Sintering on Compritol® 888 ATO Matrices. AAPS PharmSciTech 10, 355–360 (2009). https://doi.org/10.1208/s12249-009-9211-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12249-009-9211-8

Key words

  • controlled release
  • scanning electron microscopy (SEM)
  • sintering
  • wax